Mettler-Toledo International (NYSE:MTD) Price Target Cut to $1,475.00 by Analysts at Morgan Stanley

Mettler-Toledo International (NYSE:MTD) had its price objective cut by Morgan Stanley from $1,550.00 to $1,475.00 in a report issued on Tuesday morning,Benzinga reports. They currently have an equal weight rating on the medical instruments supplier’s stock.

Several other brokerages also recently commented on MTD. Wells Fargo & Company raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a report on Monday, December 29th. Barclays dropped their price objective on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a research note on Monday, December 15th. Bank of America raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 target price on the stock in a research note on Monday, December 15th. Finally, Wall Street Zen cut Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Six investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus target price of $1,435.42.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,398.30 on Tuesday. The company has a market cap of $28.43 billion, a price-to-earnings ratio of 33.20, a PEG ratio of 2.90 and a beta of 1.42. Mettler-Toledo International has a 1 year low of $946.69 and a 1 year high of $1,525.17. The firm has a fifty day moving average price of $1,419.25 and a 200-day moving average price of $1,362.19.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The business had revenue of $1.13 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same quarter in the previous year, the company posted $12.41 earnings per share. Mettler-Toledo International’s revenue for the quarter was up 8.1% on a year-over-year basis. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. Equities research analysts expect that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Activity

In other Mettler-Toledo International news, insider La Guerroniere Marc De sold 6,055 shares of Mettler-Toledo International stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the completion of the transaction, the insider directly owned 187 shares of the company’s stock, valued at $278,289.66. This trade represents a 97.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Shawn Vadala sold 1,025 shares of the company’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $1,452.00, for a total transaction of $1,488,300.00. Following the sale, the chief financial officer owned 5,288 shares in the company, valued at $7,678,176. This represents a 16.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 8,316 shares of company stock worth $12,345,015. 0.77% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Several institutional investors have recently modified their holdings of MTD. Vanguard Group Inc. lifted its position in Mettler-Toledo International by 1.3% in the third quarter. Vanguard Group Inc. now owns 2,591,173 shares of the medical instruments supplier’s stock worth $3,180,950,000 after buying an additional 34,466 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Mettler-Toledo International by 71.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after acquiring an additional 376,419 shares during the last quarter. Capital International Investors boosted its stake in shares of Mettler-Toledo International by 1.2% during the 3rd quarter. Capital International Investors now owns 859,559 shares of the medical instruments supplier’s stock worth $1,055,203,000 after purchasing an additional 10,395 shares during the period. Alliancebernstein L.P. grew its holdings in Mettler-Toledo International by 10.7% during the 3rd quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock valued at $974,633,000 after purchasing an additional 76,478 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in Mettler-Toledo International by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock worth $830,879,000 after purchasing an additional 14,106 shares during the period. 95.07% of the stock is owned by institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.